GRNY ETF Analysis: Fundstrat Granny Shots US | NYSE

Large Growth | NYSE, USA | Market Cap: 4.331m USD | 12M Return: 14.4% | Charts, Fundamentals & Technical Analysis

Large Cap Stocks, US Equities, Growth Stocks, Active Management
Total Rating 43
Safety 33
Buy Signal -0.44
Large Growth
Category Rotation: -5.3
AUM: 4.33B
Avg Turnover: 36.4M
Risk 3d forecast
Volatility16.9%
VaR 5th Pctl3.29%
VaR vs Median8.05%
Reward TTM
Sharpe Ratio0.62
Rel. Str. IBD41.9
Rel. Str. Peer Group47.7
Character TTM
Beta1.335
Beta Downside1.325
Hurst Exponent0.474
Drawdowns 3y
Max DD24.18%
CAGR/Max DD0.78
CAGR/Mean DD4.95

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 1.6 years of data

Jan -0.7% -
Feb -3.9% -
Mar -7.0% -
Apr +8.7% -
May +0.7% -
Jun -3.0% -
Jul - -
Aug - -
Sep - -
Oct - -
Nov -7.6% -
Dec -4.3% -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: GRNY Fundstrat Granny Shots US

The Fundstrat Granny Shots US Large Cap ETF (GRNY) is an actively-managed exchange-traded fund listed on the NYSE that seeks to invest in U.S. large-capitalization equity securities. Under normal market conditions, it invests at least 80% of its net assets in large-cap U.S. companies, defined as those with a market capitalization greater than $10 billion. The fund is categorized as a Large Growth ETF and launched in late 2024. Unlike passive index-tracking ETFs, GRNY uses active management, allowing its portfolio managers to selectively pick securities based on their investment strategy rather than replicating a benchmark index.

Headlines to Watch Out For
  • Fund flows accelerate past $4 billion AUM milestone
  • Federal Reserve rate cuts boost large cap growth valuations
  • Fee competition pressures active ETF expense ratios lower
What is the price of GRNY shares?

As of July 28, 2026, the stock is trading at USD 27.05 with a total of 1,241,009 shares traded. Over the past week, the price has changed by -0.59%, over one month by -1.13%, over three months by +1.77% and over the past year by +14.36%.

Current recommended Stop Loss: 26.30 (which is 2.8% or 2 ATR below the current price).

Is GRNY a buy, sell or hold?

Fundstrat Granny Shots US has no consensus analysts rating.